People & Business :: Emerging Companies
Merck KGaA Launches Venture Capital Fund for Start-Up Biotech Firms
4:58 AM MDT | March 23, 2009 | Deepti Ramesh
Merck KGaA says it has launched a venture capital fund dubbed Merck Serono Ventures, to invest in emerging biotechnology companies. The fund will support biotech start-up companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas such as neurodegenerative diseases, oncology and autoimmune & inflammatory diseases. The fund will also target companies developing innovative technologies that could enable the discovery and development of new products in Merck Serono’s core therapeutic areas. Merck Serono...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee